MAXCYTE, INC.·4

Mar 19, 4:05 PM ET

Swirsky Douglas J 4

Research Summary

AI-generated summary

Updated

MaxCyte (MXCT) CFO Douglas J. Swirsky Sells 10,142 Shares

What Happened
Douglas J. Swirsky, Chief Financial Officer of MaxCyte, sold 10,142 shares on 2026-03-17 for a reported weighted-average price of $0.81, generating proceeds of approximately $8,266. The filing indicates this was a "sale to cover" to satisfy tax withholding on vested restricted stock units (RSUs), not a discretionary sale.

Key Details

  • Transaction date: 2026-03-17; Form 4 filed: 2026-03-19.
  • Reported price: weighted average $0.81; actual sale prices ranged from $0.783 to $0.825 (multiple transactions).
  • Shares sold: 10,142; proceeds ≈ $8,266.
  • Shares owned after transaction: Not specified in the filing.
  • Footnotes: F1 notes the sale was automatically effected to cover tax withholding on vested RSUs and was not discretionary. F2 explains the weighted-average price and gives the per-share price range; the reporting person can provide a breakdown on request.
  • Transaction type: Reported as a sale (code S) associated with tax withholding.

Context
"Sale to cover" transactions are routine tax-withholding actions when equity awards vest and do not necessarily indicate the insider's market view. This filing is informational; it documents the mechanics of satisfying withholding obligations rather than a voluntary cash-raising sale.